scorpion
- 13 Aug 2003 13:54
Bioprogress is a stock I have been in and out of quite a few times since it floated in May but not much mention here on the Investors' Room. Does anyone else follow this stock. I see it is up 1.5p today and a few good buyers seem to have appeared.
Jumpin
- 18 Nov 2004 23:37
- 1465 of 2372
I must say that a company that waited for the share price to have fallen by 50% (and it seems like they have had a lot of shareholder pressure to comment before now) before issuing this statement really stinks!
I hope it bounces so I can short it!
Bones
- 18 Nov 2004 23:38
- 1466 of 2372
Nice one Limpy. Damn, I missed your take on the top at 130p, where did you post again?
:)
Seymour Clearly
- 18 Nov 2004 23:40
- 1468 of 2372
:-)
Bones
- 18 Nov 2004 23:42
- 1469 of 2372
Limpy, hehe! I think you are the first chartist on here who clearly has not read the RNS (as I know you don't). All other traders here revert to "fundamentals" when it suits their case....funny that!
Martini
- 18 Nov 2004 23:46
- 1471 of 2372
lol limpy
ok up or down tomorrow?
I say up --- paper trade and all that :)
Martini
- 18 Nov 2004 23:49
- 1473 of 2372
SENTENCE IF HOT?
Jumpin
- 18 Nov 2004 23:50
- 1475 of 2372
Up and then down more. after the news definitely a Jam tomorrow share and don't know what they are doing with the money they have or have not
Martini
- 18 Nov 2004 23:50
- 1476 of 2372
HENCE SET FIT ON?
Martini
- 18 Nov 2004 23:52
- 1477 of 2372
NO THEFTS NIECE ?
Martini
- 18 Nov 2004 23:53
- 1478 of 2372
SCENE - NOT THIEF
Martini
- 18 Nov 2004 23:54
- 1479 of 2372
o going to bed
Bones
- 18 Nov 2004 23:54
- 1481 of 2372
Jumpin - best to just SWIG your medicine and accept responsibility for the investment?
Jumpin
- 18 Nov 2004 23:58
- 1482 of 2372
LOL
Big Al
- 19 Nov 2004 02:04
- 1483 of 2372
Blimey, everyone's turned up now!
FREEDOM FOR TOOTING!
ROFLMAO!
Janus
- 19 Nov 2004 07:07
- 1484 of 2372
THE TELEGRAPH
Aim-listed biopharmaceuticals company Bioprogress fell a further 4.25 to 65.25p on heavy turnover of 22.4m shares. After the market closed, the group said its intellectual property court case against Stanelco in June will have a major impact on 2004 results, but described its long-term prospects as excellent. Bioprogress is expected to receive damages from Stanelco in early 2005.
THE GUARDIAN
Keep an eye on BioProgress, the tablet coatings maker, this morning. City dealers expect its shares to be heavily traded as investors digest the implication of last night's after-hours trading update. This said that the company will make a loss of approaching 7m. The company's broker, Collins Stewart, had been expecting BioProgress to make a profit of 1.5m. BioProgress, which started the week at 90p, closed 4.25p lower at 65.25p.
THE INDEPENDANT
The downward pressure on Bioprogress shares continued through the day, sending the stock down a further 4.25p to 65.25p. The company, which makes dissolvable coatings, has been the subject of a string of bearish rumours and finally got round to issuing a trading statement after the market closed. This revealed that a recent acquisition has underperformed, meaning it will miss revenue forecasts, but scotched more vicious rumours of problems with its development projects.
THE TIMES
Bioprogress shed 4p to 65p but is expected to open lower today after giving warning after close on slow progress on licensing deals.